High-dose vasopressin for acute variceal hemorrhage. Clinical advantages without adverse effects.

Abstract

Based on laboratory and clinical data from our institution, 113 patients with cirrhosis, portal hypertension, and acute hemorrhage from esophageal varices were treated with high-dose vasopressin arginine (1 to 1.5 U/min) to control the acute bleeding and reduce blood loss during portosystemic shunt operations. Compared with patients receiving a lower dose… (More)

Topics

  • Presentations referencing similar topics